In multiple sclerosis, aberrant splicing of exon 6 was shown to increase the production of sIL-7R [50–52] and that sIL-7R is able to potentiate IL-7 bioactivity and to promote autoimmunity [53]. This evidence concerns the gene IL7 and multiple sclerosis.